Literature DB >> 1365661

Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.

L A Holley1, P Dudchenko, M Sarter.   

Abstract

The interactions between the effects of MDL 26,479 (0.1, 0.39, 1.56, 6.25 mg/kg; IP) and the muscarinic antagonist scopolamine (0.03, 0.1 mg/kg; IP) on the performance of rats in a delayed alternation task (retention intervals: 2, 4, 8, 16, 32 s) were examined. Scopolamine dose-dependently reduced the relative number of correct responses and interacted with the effects of the length of retention intervals. MDL 26,479 did not affect correct responding but attenuated the behavioral impairments produced by scopolamine. Although this task did not explicitly exclude the possibility that the animals acquired mediational response strategies, and although the effects of scopolamine appeared to interfere with the execution of these strategies, to a major extent, the attenuative effects of MDL 26,479 were not related to its effects on mediational strategies. Thus, it is concluded that administration of MDL 26,479 mainly resulted in a re-establishment of the animals' ability to memorize and/or to recall the information required to exert correct responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365661     DOI: 10.1007/bf02245504

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  GABAergic control of basal forebrain cholinergic neurons and memory.

Authors:  P Dudchenko; M Sarter
Journal:  Behav Brain Res       Date:  1991-01-31       Impact factor: 3.332

2.  Elevations of local cerebral glucose utilization by the beta-carboline ZK 93426.

Authors:  M Sarter
Journal:  Eur J Pharmacol       Date:  1990-02-27       Impact factor: 4.432

3.  Assessment of working memory in rats using spatial alternation behavior with variable retention intervals: effects of fixed-ratio size and scopolamine.

Authors:  H E Shannon; K G Bemis; J C Hart
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence.

Authors:  H C Fibiger
Journal:  Trends Neurosci       Date:  1991-06       Impact factor: 13.837

5.  Behavioral microanalysis of spatial delayed alternation performance: rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide.

Authors:  P Dudchenko; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Bidirectional control of palatable food consumption through a common benzodiazepine receptor: theory and evidence.

Authors:  S J Cooper
Journal:  Brain Res Bull       Date:  1985-10       Impact factor: 4.077

7.  Scopolamine differentially disrupts the behavior of male and female Wistar rats in a delayed nonmatching to position procedure.

Authors:  A van Hest; J Stroet; F van Haaren; M Feenstra
Journal:  Pharmacol Biochem Behav       Date:  1990-04       Impact factor: 3.533

8.  Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

Authors:  W W Beatty; N Butters; D S Janowsky
Journal:  Behav Neural Biol       Date:  1986-03

9.  Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines.

Authors:  M Sarter; G Bodewitz; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Scopolamine produces locomotor stereotypy in an open field but apomorphine does not.

Authors:  K Mueller; J L Peel
Journal:  Pharmacol Biochem Behav       Date:  1990-07       Impact factor: 3.533

View more
  2 in total

Review 1.  Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

Authors:  M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

2.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.